Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Galectin Therapeutics Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 70 | 2 | 55 | −13 |
| Shares | 7.29M | 99.2K | 7.33M | +137.4K (+1.9%) |
| Value | $28.2M | $385.0K | $15.2M | −$12.7M (−45.6%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Galectin Therapeutics Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Synovus Financial Corp | 48,000 | $99.0K | 0.00% |
| Ameritas Advisory Services, LLC | 44,232 | $92.0K | 0.00% |
| Jump Financial, LLC | 23,200 | $48.0K | 0.00% |
| Virtu Financial LLC | 17,663 | $37.0K | 0.00% |
| Creative Planning | 11,048 | $23.0K | 0.00% |
| CoreCap Advisors, LLC | 9,195 | $19.0K | 0.00% |
| Simplex Trading, LLC | 4,306 | $8.00K | 0.00% |
Sold out (20)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ergoteles LLC | 136,320 | $529.0K |
| HRT Financial LP | 80,216 | $311.0K |
| Capstone Investment Advisors, LLC | 42,260 | $164.0K |
| Parametric Portfolio Associates LLC | 31,086 | $121.0K |
| Centaurus Financial, Inc. | 22,614 | $88.0K |
| Bank of Montreal | 20,432 | $80.0K |
| Raymond James & Associates | 13,096 | $51.0K |
| Blair William & Co | 10,756 | $42.0K |
| Meeder Asset Management Inc | 7,783 | $30.0K |
| Cutler Group LP | 3,500 | $13.0K |
| Royal Bank of Canada | 2,500 | $10.0K |
| Barclays PLC | 2,407 | $9.00K |
| UBS Group AG | 1,988 | $8.00K |
| Plante Moran Financial Advisors, LLC | 1,798 | $7.00K |
| Harbour Investments, Inc. | 284 | $1.00K |
| TCI Wealth Advisors, Inc. | 300 | $1.00K |
| Jacobi Capital Management LLC | 225 | $1.00K |
| Global Retirement Partners, LLC | 250 | $1.00K |
| Brewin Dolphin Ltd | 40 | $155 |
| Reilly Financial Advisors, LLC | 150 | – |
Not filed for Q4 2021 yet (2)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Qci Asset Management Inc | 55,000 | $213.0K |
| Ameritas Investment Company, LLC | 44,232 | $172.0K |